Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors
about
Crystallographic Fragment Screening and Structure-Based Optimization Yields a New Class of Influenza Endonuclease InhibitorsIn vitro system for modeling influenza A virus resistance under drug pressurePrediction of the pharmacodynamically linked variable of oseltamivir carboxylate for influenza A virus using an in vitro hollow-fiber infection model system.Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 Inhibitors.Impact of calcium on N1 influenza neuraminidase dynamics and binding free energy.
P2860
Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors
@ast
Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors
@en
type
label
Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors
@ast
Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors
@en
prefLabel
Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors
@ast
Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors
@en
P2093
P2860
P1476
Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors
@en
P2093
Ann C McDonough
Betty A Olson
George L Drusano
James J McSharry
P2860
P356
10.1128/CDLI.11.1.21-28.2004
P577
2004-01-01T00:00:00Z